4 Drug Stocks Facing FDA Approval Decisions in July

Description:

According to Adam Feuerstein, " Four FDA drug approval decisions in July -- headlined by another weight-loss drug and a prescription fish oil pill with blockbuster potential -- will keep biotech investors busy in what is normally one of the sector's slower months." Read more here.

>>Also: Hot Biotech Stocks Traded by Hedge Funds

>>Also: 22 Biopharma Stocks With Breakout Potential in 2012

Most Viewed Portfolios

View All

Articles

5 Stocks Under $10 Set to Soar

10.24.14 | 02:41 PM

DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for under $10 a share don't experience m...

Sell These 5 Toxic Stocks Before November

10.24.14 | 10:05 AM

BALTIMORE (Stockpickr) -- Stocks are bouncing hard in the second half of October. Since Monday, the big S&P 500 index has rallied 3.4%, more than d...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter